Skip to main content
Figure 4 | Journal of Neuroinflammation

Figure 4

From: Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury

Figure 4

Minozac suppresses proinflammatory cytokine upregulation in cortex following TBI. Mice were subjected to TBI or sham procedure. At 3 hr and 9 hr following TBI, mice were injected with Mzc (5 mg/kg/dose) or saline diluent (VEH). Mice were sacrificed at 12 hr post-injury, and levels of the proinflammatory cytokines IL-1β (A), IL6 (B), TNFα (C) and the chemokine CCL2 (D) in cortical extracts were measured by ELISA. Mzc treatment resulted in significant attenuation of the increase in cytokines measured in the TBI group treated with saline vehicle. Cytokine levels in the Mzc-treated TBI mice were not significantly different from the sham controls. Data are expressed as mean ± S.E.M of n = 5–7 animals per group. #P < 0.001 vs Sham control; **P < 0.01 vs TBI-VEH by ANOVA.

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094